![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Persistence on F/TAF versus F/TDF for HIV Pre-Exposure
Prophylaxis (PrEP): A Real-World Evidence Analysis in the United States
|
|
|
IDWeek 2021, Virtual, September 29 - October 3, 2021
Li Tao, Valentina Shvachko, Moupali Das, Christoph Carter, Jared Baeten, and David Magnuson
Gilead Sciences, Inc. Foster City, CA 94404
![1001211](../images/100121/100121-3/1001211.gif)
![1001212](../images/100121/100121-3/1001212.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|